文献速递肝病

血清25-羟维生素D与非酒精性脂肪性肝病呈反向关联

Inverse Association Between Serum 25-Hydroxyvitamin D and Nonalcoholic Fatty Liver Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-01-31

本研究采用双向孟德尔随机化方法,在歐洲人群中探讨血清25-羟维生素D(S-25(OH)D)与非酒精性脂肪性肝病(NAFLD)的关联。利用7个和6个独立遗传变异作为工具变量,汇总数据来自79,366人的S-25(OH)D研究及三个NAFLD数据源。结果显示,遗传预测的S-25(OH)D每升高1个标准差,NAFLD合并比值比为0.78(95%CI 0.69-0.89);反向分析未发现NAFLD对S-25(OH)D有因果影响。

要点

  • 遗传预测的S-25(OH)D水平升高与NAFLD风险降低相关,合并OR为0.78(95%CI 0.69-0.89)。
  • 反向孟德尔随机化未发现NAFLD遗传易感性与S-25(OH)D水平相关。
  • 作者认为在歐洲人群中增加维生素D水平可能对预防NAFLD有作用。

核心结论

  • 遗传预测的S-25(OH)D水平较高与NAFLD风险降低一致相关,合并OR为0.78(95%CI 0.69-0.89)。
  • 遗传易感性NAFLD与S-25(OH)D无关联(变化值0.13;95%CI -1.26至0.53)。
  • 作者认为在歐洲人群中增加维生素D水平可能对预防NAFLD有作用。

研究设计与样本

  • 双向孟德尔随机化研究,选取7个与S-25(OH)D相关和6个与NAFLD相关的独立遗传变异作为工具变量。
  • S-25(OH)D汇总数据来自Study of Underlying Genetic Determinants of Vitamin D and Highly Related Traits联盟,共79,366人。
  • NAFLD汇总数据来自全基因组关联荟萃分析(1483例病例和17,781例对照)、FinnGen联盟(894例病例和217,898例对照)和UK Biobank研究(275例病例和360,919例对照)。
  • 4种肝酶的汇总数据来自UK Biobank。

主要发现

  • 遗传预测的S-25(OH)D水平每升高1个标准差,NAFLD合并OR为0.78(95%CI 0.69-0.89)。
  • 遗传预测的S-25(OH)D较高与天冬氨酸氨基转移酶水平呈临界关联(变化值-1.17;95%CI -1.36至0.01)。
  • 遗传易感性NAFLD与S-25(OH)D无关联(变化值0.13;95%CI -1.26至0.53)。
  • S-25(OH)D与NAFLD及某些肝酶存在遗传相关性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Serum 25-hydroxyvitamin D [S-25(OH)D] and nonalcoholic fatty liver disease (NAFLD) are correlated in many observational studies, whereas the causality of this association is uncertain, especially in European populations. We conducted a bidirectional Mendelian randomization study to determine the association between S-25(OH)D and NAFLD. METHODS: Seven and 6 independent genetic variants associated with S-25(OH)D and NAFLD at the genome-wide-significance level, respectively, were selected as instrumental variables. Summary-level data for S-25(OH)D were obtained from the Study of Underlying Genetic Determinants of Vitamin D and Highly Related Traits consortium including 79,366 individuals. Summary-level data for NAFLD were available from a genome-wide association meta-analysis (1483 cases and 17,781 controls), the FinnGen consortium (894 cases and 217,898 controls), and the UK Biobank study (275 cases and 360,919 controls). Summary-level data for 4 liver enzymes were obtained from the UK Biobank. RESULTS: There were genetic correlations of S-25(OH)D with NAFLD and certain liver enzymes. Genetically predicted higher levels of S-25(OH)D were consistently associated with a decreased risk of NAFLD in the 3 sources. For a 1-SD increase in genetically predicted S-25(OH)D levels, the combined odds ratio of NAFLD was 0.78 (95% confidence interval [CI], 0.69 to 0.89). Genetically predicted higher levels of S-25(OH)D showed a borderline association with aspartate aminotransferase levels (change -1.17; 95% CI, -1.36 to 0.01). Genetic predisposition to NAFLD was not associated with S-25(OH)D (change 0.13; 95% CI, -1.26 to 0.53). CONCLUSIONS: Our findings have clinical implications as they suggest that increased vitamin D levels may play a role in NAFLD prevention in European populations.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Yuan S, Larsson SC. Inverse Association Between Serum 25-Hydroxyvitamin D and Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2022. PMID: 35101633. doi:10.1016/j.cgh.2022.01.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。